2-amino-7-methoxymitosene 1-uridylate uridilic acid salt
英文别名
——
CAS
132019-12-6
化学式
C9H13N2O9P*C24H28N5O14P
mdl
——
分子量
965.669
InChiKey
BTZXHZPOVQRJMU-QFSJXCATSA-N
BEILSTEIN
——
EINECS
——
物化性质
计算性质
ADMET
安全信息
SDS
制备方法与用途
上下游信息
反应信息
文献信息
表征谱图
同类化合物
相关功能分类
相关结构分类
计算性质
辛醇/水分配系数(LogP):
-4.67
重原子数:
65.0
可旋转键数:
13.0
环数:
7.0
sp3杂化的碳原子比例:
0.48
拓扑面积:
458.26
氢给体数:
11.0
氢受体数:
24.0
反应信息
作为产物:
描述:
尿苷5-单磷酸 、 mitomycin A 以
1,4-二氧六环 为溶剂,
反应 3.0h,
以25%的产率得到2-amino-7-methoxymitosene 1-uridylate uridilic acid salt
参考文献:
名称:
Additional nucleotide derivatives of mitosenes. Synthesis and activity against parental and multidrug resistant L1210 leukemia
摘要:
Cytidine 5'-monophosphate and 5'-ara-CMP conjugates of 2,7-diaminomitosene, with the phosphate groups linked to C-1, were prepared by treating mitomycin C with the appropriate nucleotides. 5'-UMP conjugates were prepared from mitomycin A, 7 (M-83), and 8 (BMY-25282) by similar procedures. A conjugate could not be prepared from mitomycin C and 6-MPRP, but a sulfur-linked derivative was made with 6-MP ribonucleoside. The corresponding 1-hydroxy-2-aminomitosenes were prepared from the parent mitomycin analogues for structure-activity comparisons. All compounds were tested against L1210 murine leukemia in the MTT tetrazolium dye assay. In general, the conjugates were less potent than the parent mitomycins; however 5'-ara-CMP conjugate 14 derived from mitomycin C was more potent than the parent compound or any mitomycin tested except mitomycin A. It also was more potent than ara-C. This result establishes the value of this approach to prodrugs, at least in cell culture. Against a multidrug-resistant L1210 cell line, all of the conjugates derived from mitomycin C were more potent than the parent compound. 6-Mercaptopurine ribonucleoside conjugate 15 was more active against the resistant cells than it was against the parental cell line.